Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane Le Bras

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Trials|March 22, 2021
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trialBenjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, et al.
The Journal of Cell Biology|September 20, 2006
Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIADelphine Poncet, Anne-Laure Pauleau, Gyorgy Szabadkai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2026
Decoding the Integrated Stress Response of Pancreatic Cancer: Identifying a Serine-dependent Tumor Subset Under Metabolic Relationships With CAFsSauyeun Shin, Mehdi Liauzun, Jacobo Solorzano, et al.
Human Molecular Genetics|February 5, 2013
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort studyJulien Thevenon, Abderrahmane Bourredjem, Laurence Faivre, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Trials|March 22, 2021
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trialBenjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, et al.
The Journal of Cell Biology|September 20, 2006
Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIADelphine Poncet, Anne-Laure Pauleau, Gyorgy Szabadkai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2026
Decoding the Integrated Stress Response of Pancreatic Cancer: Identifying a Serine-dependent Tumor Subset Under Metabolic Relationships With CAFsSauyeun Shin, Mehdi Liauzun, Jacobo Solorzano, et al.
Human Molecular Genetics|February 5, 2013
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort studyJulien Thevenon, Abderrahmane Bourredjem, Laurence Faivre, et al.
Pageof 4